147 related articles for article (PubMed ID: 10099057)
21. Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador.
Elluru S; Duong Van Huyen JP; Delignat S; Prost F; Bayry J; Kazatchkine MD; Kaveri SV
Arzneimittelforschung; 2006 Jun; 56(6A):461-6. PubMed ID: 16927527
[TBL] [Abstract][Full Text] [Related]
22. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
[TBL] [Abstract][Full Text] [Related]
23. Decrease of activated lymphocytes four and nine hours after a subcutaneous injection of a Viscum album L. extract in healthy volunteers.
Stoss M; Peter E; Gorter RW
Nat Immun; 1998; 16(5-6):185-97. PubMed ID: 11061587
[TBL] [Abstract][Full Text] [Related]
24. Prevention of 20-methylcholanthrene-induced sarcoma by a mistletoe extract, Iscador.
Kuttan G; Menon LG; Kuttan R
Carcinogenesis; 1996 May; 17(5):1107-9. PubMed ID: 8640920
[TBL] [Abstract][Full Text] [Related]
25. No evidence of IFN-gamma increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented viscum album L. extract.
Stoss M; Gorter RW
Nat Immun; 1998; 16(4):157-64. PubMed ID: 10366786
[TBL] [Abstract][Full Text] [Related]
26. Changes in immunological characteristics of white blood cells after administration of standardized mistletoe extract.
Klopp R; Schmidt W; Niemer W; Werner M; Beuth J
In Vivo; 2001; 15(6):447-57. PubMed ID: 11887328
[TBL] [Abstract][Full Text] [Related]
27. Effects of Iscador preparations on the reactivity of mouse immune system.
Gren A
Neuro Endocrinol Lett; 2009; 30(4):530-4. PubMed ID: 20010495
[TBL] [Abstract][Full Text] [Related]
28. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
Maldacker J
Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
[TBL] [Abstract][Full Text] [Related]
30. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
Kaegi E
CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
[No Abstract] [Full Text] [Related]
31. Cytostatic and cytocidal effects of mistletoe (Viscum album L.) quercus extract Iscador.
Kovacs E; Link S; Toffol-Schmidt U
Arzneimittelforschung; 2006 Jun; 56(6A):467-73. PubMed ID: 16927528
[TBL] [Abstract][Full Text] [Related]
32. Subcutaneous inflammation mimicking metastatic malignancy induced by injection of mistletoe extract.
Finall AI; McIntosh SA; Thompson WD
BMJ; 2006 Dec; 333(7582):1293-4. PubMed ID: 17185712
[No Abstract] [Full Text] [Related]
33. In vitro immunoreactivity towards lectin-rich or viscotoxin-rich mistletoe (Viscum album L.) extracts Iscador applied to healthy individuals.
Huber R; Classen K; Werner M; Klein R
Arzneimittelforschung; 2006 Jun; 56(6A):447-56. PubMed ID: 16927525
[TBL] [Abstract][Full Text] [Related]
34. Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study.
Kim KC; Yook JH; Eisenbraun J; Kim BS; Huber R
BMC Complement Altern Med; 2012 Oct; 12():172. PubMed ID: 23033982
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M).
Kirsch A
J Altern Complement Med; 2007 May; 13(4):443-5. PubMed ID: 17532738
[TBL] [Abstract][Full Text] [Related]
36. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the effect of mistletoe (Viscum album L.) extract Iscador on the proliferation and apoptosis of murine thymocytes.
Hajtò T; Berki T; Pàlinkàs L; Boldizsàr F; Németh P
Arzneimittelforschung; 2006 Jun; 56(6A):441-6. PubMed ID: 16927524
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
[TBL] [Abstract][Full Text] [Related]
40. Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects.
Huber R; Rostock M; Goedl R; Lüdtke R; Urech K; Buck S; Klein R
Eur J Med Res; 2005 Oct; 10(10):411-8. PubMed ID: 16287602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
